Trade Summary

5 days ago, Davis Todd C, serving as Dir at Pelthos Therapeutics Inc. (PTHS), purchased 35,948 shares at $27.82 per share, for a total transaction value of $999,983.28. Following this transaction, Davis Todd C now holds 75,834 shares of PTHS.

This purchase represents a 90.13% increase in Davis Todd C's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 11, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 15, 2026 at 5:25 PM ET, 4 days after the trade was made.

Pelthos Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.